Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30

$1.58−0.08 (-4.82%)

Close on Nov 13, 2026Market cap $561.78MP/E –Yield –

Evotec price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Evotec's price to sales ratio was 0.7× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.6× to 13.7×, with a median of 2.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	0.7×	−0.5
2025	Dec 31, 2025	1.2×	−0.7
2024	Dec 31, 2024	1.8×	−3.2
2023	Dec 29, 2023	5.0×	+0.7
2022	Dec 30, 2022	4.3×	−9.4
2021	Dec 31, 2021	13.7×	+3.7
2020	Dec 31, 2020	10.1×	–